ArticleCancer research2025

Recharacterization of the Tumor Suppressive Mechanism of RSL3 Identifies the Selenoproteome as a Druggable Pathway in Colorectal Cancer.

Stephen L DeAngelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.